by
Danish Siddiqui February 3, 2023
Pertuzumab is a recombinant humanized monoclonal antibody used to treat HER2-positive breast cancer. The antibody works by binding to the HER2 receptor, which is a protein that is over-expressed in some types of breast cancer. Pertuzumab was approved for use in metastatic and locally advanced HER2-p...